Jesus Aureliano Robles-de Anda

Dr. Jesus Aureliano Robles-de Anda

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020
Verified
Book Chapter
Open access
PDF file
FCFernanda-Isadora Corona-Meraz
Fernanda-Isadora Corona-Meraz
JAJesus Aureliano Robles-de Anda
Jesus Aureliano Robles-de Anda
PMPerla Monserrat Madrigal-Ruiz
Perla Monserrat Madrigal-Ruiz
GDGustavo-Ignacio Díaz-Rubio
Gustavo-Ignacio Díaz-Rubio
JAJorge Castro Albarrán
Jorge Castro Albarrán
RNRosa Elena Navarro
Rosa Elena Navarro
Obesity, being an epidemy these days, is the trigger of metabolic disturbances such as cardiovascular disease, type 2 diabetes, and insulin resistance. Defined as an increase in fat storage, adipose tissue has been put under the spotlight as the culprit of these conditions, as it is composed not only by adipocytes but of any immune system cell and a singular extracellular matrix. Its behavior under acute and chronic hypercaloric states is quite different; persistent hypertrophy in the latter creates hypoxia, resulting in the release of reactive oxygen species and proinflammatory cytokines that impact on the immune response type of the resident leucocytes, mainly macrophages. Hypertrophy over hyperplasia, adipose tissue macrophages-M1 phenotype polarization, and the adipokines/myokines profile are thought to be regulated by foreign microRNAs, delivered from surrounding or distant cells by exosomes through the bloodstream. In this chapter, we focus on adipose tissue immunometabolism and how obesity causes the chronic inflammatory state, and, subsequently, this stablishes a pathologic adiposity, characterized by dyslipidemia and insulin resistance (IR).